10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q1 2014

Filing Information

Form Type	10-Q
Accession Number	`0001144204-14-050240`
Period End Date	20140630
Filing Date	20140814
Fiscal Year	2014
Fiscal Period	Q1
XBRL Instance	ameh-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 36 Cash Flow Statement 58 Stockholders Equity 9

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.46M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.76M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable securities	`MarketableSecurities`	-	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable securities	`MarketableSecurities`	$407.68K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$40.00K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$20.00K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.51M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	49.13M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.53M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	49.13M	shares	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$38.64K	USD	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$24.04K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	49.13M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	49.13M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$59.66K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$42.20K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.43M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.84M	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$337.98K	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$366.29K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$94.95K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$99.22K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$59.63K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$211.43K	USD	Point-in-time
Goodwill	`Goodwill`	$494.70K	USD	Point-in-time
Goodwill	`Goodwill`	$278.13K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$38.68K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$41.64K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.48M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$8.81M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.48M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.45M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.14M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$552.56K	USD	Point-in-time
Note and line of credit payable , net of discount -current portion	`NotesAndLinesOfCreditPayableCurrent`	$444.76K	USD	Point-in-time
Note and line of credit payable , net of discount -current portion	`NotesAndLinesOfCreditPayableCurrent`	$392.26K	USD	Point-in-time
Holdback liability	`HoldbackConsideration`	$136.82K	USD	Point-in-time
Holdback liability	`HoldbackConsideration`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.15M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.44M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.38M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Notes payable, net of discount - non current portion	`LongTermNotesPayable`	$5.28M	USD	Point-in-time
Notes payable, net of discount - non current portion	`LongTermNotesPayable`	$5.34M	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$981.69K	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$962.98K	USD	Point-in-time
Total liabilities	`Liabilities`	$11.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.80M	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 49,134,549 shares issued and outstanding as of June 30, 2014 and March 31, 2014, respectively	`CommonStockValue`	$49.13K	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 49,134,549 shares issued and outstanding as of June 30, 2014 and March 31, 2014, respectively	`CommonStockValue`	$49.13K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$15.20M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$15.08M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$18.59K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-18.03M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-1.22M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-2.76M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-408.07K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-237.86K	USD	Point-in-time
Total	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.99M	USD	Point-in-time
Total	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$8.81M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$9.48M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$4.09M	USD	1 Quarter
Net revenues	`Revenues`	$2.61M	USD	1 Quarter
Cost of services	`CostOfServices`	$3.26M	USD	1 Quarter
Cost of services	`CostOfServices`	$2.46M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.01M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.92M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.36K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.90K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$4.39M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$5.28M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.77M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.19M	USD	1 Quarter
Interest expense	`InterestExpense`	$161.69K	USD	1 Quarter
Interest expense	`InterestExpense`	$276.87K	USD	1 Quarter
Other	`OtherNonoperatingIncome`	$1.05K	USD	1 Quarter
Other	`OtherNonoperatingIncome`	$-32.48K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-309.35K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-160.64K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.50M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.93M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$800.00	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$11.60K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.93M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.51M	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$170.21K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.68M	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.93M	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$18.59K	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.66M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.93M	USD	1 Quarter
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING - BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	49.13M	shares	1 Quarter
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING - BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	35.44M	shares	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.93M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.51M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$6.36K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$11.90K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$1.55M	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$119.14K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$11.80K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$28.31K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$79.38K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$44.66K	USD	1 Quarter
Change in fair value of warrant liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Change in fair value of warrant liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-30.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-4.27K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-346.38K	USD	1 Quarter
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-17.71K	USD	1 Quarter
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$20.48K	USD	1 Quarter
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-52.00	USD	1 Quarter
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$5.27K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-2.96K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-4.80K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$109.93K	USD	1 Quarter
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-4.30K	USD	1 Quarter
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-163.68K	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$160.62K	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.10M	USD	1 Quarter
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	1 Quarter
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$-216.36K	USD	1 Quarter
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.53K	USD	1 Quarter
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.97K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$204.39K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-7.53K	USD	1 Quarter
Principal payments on term note payable	`PrincipalPaymentsOnTermNotePayable`	-	USD	1 Quarter
Principal payments on term note payable	`PrincipalPaymentsOnTermNotePayable`	$175.00K	USD	1 Quarter
Payment of note payable	`RepaymentsOfNotesPayable`	-	USD	1 Quarter
Payment of note payable	`RepaymentsOfNotesPayable`	$94.77K	USD	1 Quarter
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	-	USD	1 Quarter
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$120.00K	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromSubscribedCommonStock`	-	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromSubscribedCommonStock`	$-430.44K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-175.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$215.68K	USD	1 Quarter
NET (DECREASE) INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$368.77K	USD	1 Quarter
NET (DECREASE) INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.07M	USD	1 Quarter
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.46M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.76M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.46M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.76M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Interest paid	`InterestPaid`	$150.49K	USD	1 Quarter
Interest paid	`InterestPaid`	$105.23K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$6.40K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	$11.13K	USD	1 Quarter
Holdback Liability	`HoldbackLiability`	-	USD	1 Quarter
Holdback Liability	`HoldbackLiability`	$136.82K	USD	1 Quarter

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.99M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Net (loss) income	`ProfitLoss`	$-1.93M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.51M	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$18.59K	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$119.14K	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.99M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.